Unlock instant, AI-driven research and patent intelligence for your innovation.

System for editing CYP4F8 gene and application thereof

A CYP4F8, encoding nucleic acid technology, applied in genetic engineering, cells modified by introducing foreign genetic material, enzymes, etc., can solve problems such as reducing the viability of prostate cancer cells

Pending Publication Date: 2022-06-03
NANJING BIOHENG BIOTECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that even partial knockdown of CYP4F8 expression can significantly reduce the cell viability of prostate cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • System for editing CYP4F8 gene and application thereof
  • System for editing CYP4F8 gene and application thereof
  • System for editing CYP4F8 gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1. sgRNA vector construction

[0018] Using the CRISPR online design tool (http: / / crispr.mit.edu / ), according to the scoring system, the sgRNA spacer sequences were designed for exon 1, exon 2, exon 4, and exon 6 of CYP4F8, respectively. , and the corresponding oligonucleotide chains were designed according to the sgRNA spacer sequence, the sequences of which are shown in Table 2 and Table 3 below, respectively.

[0019] Table 2. Spacer sequences of sgRNAs

[0020]

[0021]

[0022] Table 3. Oligonucleotide sequences of sgRNA spacer sequences

[0023] name Oligonucleotide sequence sgRNA-1oligo1 5'-caccgAAGAACCAGTTCTGTTTCCG-3' (SEQ ID NO: 17) sgRNA-1oligo2 5'-aaacCGGAAACAGAACTGGTTCTTc-3' (SEQ ID NO: 18) sgRNA-2oligo1 5'-caccgATGACAGATCGGACGATGTC-3' (SEQ ID NO: 19) sgRNA-2oligo2 5'-aaacGACATCGTCCGATCTGTCATc-3' (SEQ ID NO: 20) sgRNA-3oligo1 5'-caccgAGGCAGGCGTCAGCAAGCGA-3' (SEQ ID NO: 21) sgRNA-3oligo2 5'-a...

Embodiment 2

[0025] Example 2. Cell transfection and detection of knockout efficiency

[0026] The LentiCRISPR V2 plasmid carrying the sgRNA sequence was transfected into 293T cells using lipofection. Specifically, 293T cells were inoculated with complete medium (high glucose DMEM medium with 10% fetal bovine serum) in advance, and cultured in a 5% CO2, 37°C constant temperature incubator for 1 day, until the cells reached 70-90% confluence when transfected. Transfection reagent (125 μl Opti-MEM, 3.75 μl Lipo3000R) and DNA premix (125 μl Opti-MEM, 5 μg LentiCRISPR V2 plasmid, 10 μl P3000 TM ) were mixed at a ratio of 1:1 and added to 293T cells after 5 min incubation at 25°C. After the cells were placed in a 37°C incubator for 48-72 hours, the complete medium containing 1 ng / ml puromycin was used for resistance screening, and the positive cells were recovered and cultured in the complete medium for 2-3 days. The cells were collected, and the gene knockout efficiency was identified by th...

Embodiment 3

[0030] Example 3. Gene Expression Verification

[0031] The RNA of the positive 293T cells screened by puromycin was extracted and reverse transcribed into cDNA, and the following primers were used to detect the expression of CYP4F8 gene in the cells. The results are shown in Table 5.

[0032] P-F: TCTTCGCAATCCATCACAAC (SEQ ID NO: 25)

[0033] P-R: ACCACCTTCATCTCTGCCA (SEQ ID NO: 26)

[0034] Table 5. CY4F8 expression levels

[0035]

[0036] It can be seen that the expression of CYP4F8 in 293T cells knocked out by sgRNA-2 is the lowest, and the knockout effect is the best.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to editing of a CYP4F8 gene, in particular to screening of an sgRNA sequence which aims at CYP4F8 and is relatively high in knockout efficiency, and a spacer sequence contained in the sgRNA sequence is as shown in SEQ ID NO: 14.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering and genetic modification, and relates to the editing of CYP4F8 gene based on CRISPR / Cas9 technology and its use. Background technique [0002] CYP4F8 is a cytochrome P450 monooxygenase that oxidizes and hydroxylates COX products to 19-hydroxy-PGE2. PGE2 can stimulate various prostate receptor subtypes, while 19-hydroxy-PGE2 exhibits selectivity for EP2 receptor subtypes. In prostate cancer, EP2 receptor binding to PGE2 induces vascular endothelial growth factor (VEGF) secretion, cell motility, growth, and angiogenesis. Studies have shown that even partial knockdown of CYP4F8 expression significantly reduces cell viability in prostate cancer cells. Therefore, the prostate-specific expression profile of CYP4F8 and the activation of the EP2 receptor by 19-hydroxy-PGE2 suggest that inhibition of CYP4F8 may be an attractive treatment for prostate cancer. SUMMARY OF THE INVENTION [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N9/22C12N5/10
CPCC12N15/1137C12N9/22C12N9/0081C12N2310/20
Inventor 刘启慧黄童赵恩峰王延宾贺小宏任江涛韩露
Owner NANJING BIOHENG BIOTECH CO LTD